glycyrrhizic acid has been researched along with Infections, Coronavirus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, X; Jiang, Y; Liu, C; Qu, F; Xi, H; Zhao, X; Zhao, Y | 1 |
| Li, J; Liu, D; Luo, P | 1 |
| Gao, R; Guo, T; Huan, C; Jiang, L; Kang, Y; Xu, W; Zhang, Y | 1 |
| Chen, L; Du, J; Hood, M; Hu, C; Kan, J; Zhang, L; Zhang, X | 1 |
| Bai, C; Chang, H; Guo, R; Leung, E; Li, P; Liu, H; Liu, T; Wang, J; Wang, Y; Wu, S; Yang, R; Zhang, X | 1 |
| Bailly, C; Vergoten, G | 1 |
| Ding, H; Hu, Y; Li, H; Li, S; Tang, H; Zhai, S; Zhao, R | 1 |
3 review(s) available for glycyrrhizic acid and Infections, Coronavirus
| Article | Year |
|---|---|
Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antimalarials; Antiviral Agents; Basal Metabolism; Betacoronavirus; Cardiovascular Physiological Phenomena; Chloroquine; Congenital Abnormalities; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Drug Combinations; Drug Delivery Systems; Female; Functional Residual Capacity; Glycyrrhizic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Interferon Type I; Lopinavir; Metformin; Nanoparticles; Oxygen Consumption; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Prognosis; Respiratory Physiological Phenomena; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Stillbirth; Ventilation-Perfusion Ratio | 2020 |
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
Topics: Alarmins; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Glycyrrhizic Acid; Humans; Hydroxychloroquine; Membrane Microdomains; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tenofovir | 2020 |
The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS.
Topics: Anti-Inflammatory Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glycyrrhizic Acid; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Treatment Outcome | 2020 |
4 other study(ies) available for glycyrrhizic acid and Infections, Coronavirus
| Article | Year |
|---|---|
Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Glycyrrhizic Acid; Humans; Interferons; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Virus Attachment; Virus Internalization | 2020 |
Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.
Topics: Animals; Cells, Cultured; Chlorocebus aethiops; Coronavirus Infections; Glycyrrhizic Acid; HMGB1 Protein; p38 Mitogen-Activated Protein Kinases; Porcine epidemic diarrhea virus; Signal Transduction; Swine; Swine Diseases; Toll-Like Receptor 4; Vero Cells | 2020 |
A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis.
Topics: Anti-Inflammatory Agents; Ascorbic Acid; Coronavirus; Coronavirus Infections; Curcuma; Curcumin; Cytokines; Drug Combinations; Drug Delivery Systems; Gene Ontology; Glycyrrhiza; Glycyrrhizic Acid; Humans; Immunity, Innate; Inflammation; Interferons; Plant Extracts; Signal Transduction; Systems Biology; T-Lymphocytes; Vitamins | 2020 |
Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study.
Topics: Animals; Anti-Inflammatory Agents; Betacoronavirus; Cells, Cultured; Computer Simulation; Coronavirus Infections; COVID-19; Drugs, Chinese Herbal; Gene Expression; Glycyrrhizic Acid; Humans; Interleukin-6; Lipopeptides; Lipopolysaccharides; Male; Pandemics; Pneumonia; Pneumonia, Viral; Rats; SARS-CoV-2; Signal Transduction; Thrombin; Toll-Like Receptors | 2020 |